ADC Therapeutics (ADCT) Net Equity Issued and Repurchased (2019 - 2026)
ADC Therapeutics (ADCT) reported Net Equity Issued and Repurchased of $118,000 for Q2 2026, down 99.8% from $50.49 million a year earlier and down 42.4% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ADC Therapeutics' Net Equity Issued and Repurchased came in at $86.33 million, up 74.3% year-over-year; for FY2025, it was $86.28 million, up 42.6% from FY2024.
- By year, Net Equity Issued and Repurchased came in at $60.51 million in FY2024 and $773,000 in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | ADC Therapeutics | 192.88 Mn | -707.77 Mn | 19.74 Mn | -605,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -605,000.00 |
| Jun 30, 2026 | 118,000.00 |
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 58.35 Mn |
| Sep 30, 2025 | -198,000.00 |
| Jun 30, 2025 | 94.03 Mn |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | -879,000.00 |
| Jun 30, 2024 | 98.70 Mn |
| Mar 31, 2024 | 356,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 349,000.00 |
| Mar 31, 2023 | 425,000.00 |
| Dec 31, 2022 | -62,000.00 |
| Sep 30, 2022 | 6.19 Mn |
| Dec 31, 2021 | 262,000.00 |
| Sep 30, 2021 | 282,000.00 |
| Jun 30, 2021 | 231,000.00 |
| Mar 31, 2021 | 3,000.00 |
API Access
ADC Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();